OR5J7P

Across TCGA pan-cancer cohorts, OR5J7P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated OR5J7P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher OR5J7P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR5J7P expression acts as an unfavorable survival marker.

KIRC, KIRP, and BLCA are the cancer types where OR5J7P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Tertile	All	0.573	0.810	<.001	78	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	63	view →
BLCA	DFS	Tertile	All	0.181	0.629	<.001	36	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
SKCM	DFS	Tertile	III,IV	0.058	0.648	.001	9	view →
HNSC	OS	Tertile	II,III,IV	0.326	0.652	.039	9	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

OR5J7P–KIRC (OS)

Open the KIRC breakdown →